AIRDF (Rocket Doctor AI) Research & Development: $0.32 Mil (TTM As of Mar. 2026)


AIRDF Rocket Doctor AI Inc AIRDF
29 GF Score
Price $0.44
! 7 Warning Signs
View Full Analysis

What is Rocket Doctor AI Research & Development?

Rocket Doctor AI AIRDF +0.50% 29 Research & Development is $0.32 Mil as of Mar. 2026. GuruFocus rates AIRDF with a GF Score™ of 29/100. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rocket Doctor AI's Research & Development for the three months ended in Mar. 2026 was $0.25 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.32 Mil.

Rocket Doctor AI  (OTCPK:AIRDF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rocket Doctor AI Research & Development Related Terms

Rocket Doctor AI Research & Development Historical Data

* Premium members only.

The historical data trend for Rocket Doctor AI's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rocket Doctor AI Research & Development Chart

Rocket Doctor AI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 1.71 0.43 0.26 0.34 0.14

Rocket Doctor AI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 -0.00 -0.00 0.25
AIRDF
29GF Score
Rocket Doctor AI Inc AIRDF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rocket Doctor AI Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.32 Mil mean?
Rocket Doctor AI (AIRDF) has a Research & Development of $0.32 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Rocket Doctor AI and its competitors.
Is Rocket Doctor AI's Research & Development too high?
Rocket Doctor AI's current Research & Development is $0.32 Mil. Overall, Rocket Doctor AI has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Rocket Doctor AI's Research & Development compare to VEEV and BTSG?
Rocket Doctor AI's Research & Development of $0.32 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rocket Doctor AI and its competitors. Rocket Doctor AI's current Research & Development is $0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rocket Doctor AI stock overvalued right now?
Rocket Doctor AI (AIRDF) has a current Research & Development of $0.32 Mil. The current Research & Development is $0.32 Mil. Rocket Doctor AI's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rocket Doctor AI (AIRDF), the current Research & Development is $0.32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rocket Doctor AI Business Description

Other Exchanges 9390:GermanyAIDR:Canada
Address 700-838 W Hastings Street, Vancouver, BC, CAN, V6C 0A6
Rocket Doctor AI Inc delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians world-wide. Alongside the GLM and its AI-powered digital health platform and marketplace. The group empowers over 300 MDs to provide care to more than 700,000 patients. Its proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
29GF Score

Get the complete analysis for AIRDF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price